Literature DB >> 11861901

Identification of HDAC10, a novel class II human histone deacetylase containing a leucine-rich domain.

Jenny J Tong1, Jianhong Liu, Nicholas R Bertos, Xiang-Jiao Yang.   

Abstract

Histone acetylation is important for regulating chromatin structure and gene expression. Three classes of mammalian histone deacetylases have been identified. Among class II, there are five known members, namely HDAC4, HDAC5, HDAC6, HDAC7 and HDAC9. Here we describe the identification and characterization of a novel class II member termed HDAC10. It is a 669 residue polypeptide with a bipartite modular structure consisting of an N-terminal Hda1p-related putative deacetylase domain and a C-terminal leucine-rich domain. HDAC10 is widely expressed in adult human tissues and cultured mammalian cells. It is enriched in the cytoplasm and this enrichment is not sensitive to leptomycin B, a specific inhibitor known to block the nuclear export of other class II members. The leucine-rich domain of HDAC10 is responsible for its cytoplasmic enrichment. Recombinant HDAC10 protein possesses histone deacetylase activity, which is sensitive to trichostatin A, a specific inhibitor for known class I and class II histone deacetylases. When tethered to a promoter, HDAC10 is able to repress transcription. Furthermore, HDAC10 interacts with HDAC3 but not with HDAC4 or HDAC6. These results indicate that HDAC10 is a novel class II histone deacetylase possessing a unique leucine-rich domain.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11861901      PMCID: PMC101247          DOI: 10.1093/nar/30.5.1114

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  77 in total

1.  Differential localization of HDAC4 orchestrates muscle differentiation.

Authors:  E A Miska; E Langley; D Wolf; C Karlsson; J Pines; T Kouzarides
Journal:  Nucleic Acids Res       Date:  2001-08-15       Impact factor: 16.971

Review 2.  Control of muscle development by dueling HATs and HDACs.

Authors:  T A McKinsey; C L Zhang; E N Olson
Journal:  Curr Opin Genet Dev       Date:  2001-10       Impact factor: 5.578

3.  Cloning and characterization of a histone deacetylase, HDAC9.

Authors:  X Zhou; P A Marks; R A Rifkind; V M Richon
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-04       Impact factor: 11.205

Review 4.  Transcription regulation by histone methylation: interplay between different covalent modifications of the core histone tails.

Authors:  Y Zhang; D Reinberg
Journal:  Genes Dev       Date:  2001-09-15       Impact factor: 11.361

Review 5.  Translating the histone code.

Authors:  T Jenuwein; C D Allis
Journal:  Science       Date:  2001-08-10       Impact factor: 47.728

6.  The modular nature of histone deacetylase HDAC4 confers phosphorylation-dependent intracellular trafficking.

Authors:  X Zhao; A Ito; C D Kane; T S Liao; T A Bolger; S M Lemrow; A R Means; T P Yao
Journal:  J Biol Chem       Date:  2001-07-24       Impact factor: 5.157

7.  Identification of components of the murine histone deacetylase 6 complex: link between acetylation and ubiquitination signaling pathways.

Authors:  D Seigneurin-Berny; A Verdel; S Curtet; C Lemercier; J Garin; S Rousseaux; S Khochbin
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

8.  Human HDAC7 histone deacetylase activity is associated with HDAC3 in vivo.

Authors:  W Fischle; F Dequiedt; M Fillion; M J Hendzel; W Voelter; E Verdin
Journal:  J Biol Chem       Date:  2001-07-20       Impact factor: 5.157

Review 9.  Histone deacetylase inhibitors as new cancer drugs.

Authors:  P A Marks; V M Richon; R Breslow; R A Rifkind
Journal:  Curr Opin Oncol       Date:  2001-11       Impact factor: 3.645

10.  Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila.

Authors:  J S Steffan; L Bodai; J Pallos; M Poelman; A McCampbell; B L Apostol; A Kazantsev; E Schmidt; Y Z Zhu; M Greenwald; R Kurokawa; D E Housman; G R Jackson; J L Marsh; L M Thompson
Journal:  Nature       Date:  2001-10-18       Impact factor: 49.962

View more
  51 in total

Review 1.  Class II histone deacetylases: from sequence to function, regulation, and clinical implication.

Authors:  Xiang-Jiao Yang; Serge Grégoire
Journal:  Mol Cell Biol       Date:  2005-04       Impact factor: 4.272

2.  Human MI-ER1 alpha and beta function as transcriptional repressors by recruitment of histone deacetylase 1 to their conserved ELM2 domain.

Authors:  Zhihu Ding; Laura L Gillespie; Gary D Paterno
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

Review 3.  50 years of protein acetylation: from gene regulation to epigenetics, metabolism and beyond.

Authors:  Eric Verdin; Melanie Ott
Journal:  Nat Rev Mol Cell Biol       Date:  2014-12-30       Impact factor: 94.444

4.  Histone deacetylase 10 suppresses proliferation and invasion by inhibiting the phosphorylation of β-catenin and serves as an independent prognostic factor for human clear cell renal cell carcinoma.

Authors:  Wenxing Fan; Jie Huang; Hua Xiao
Journal:  Int J Clin Exp Med       Date:  2015-03-15

Review 5.  Alcohol-induced protein hyperacetylation: mechanisms and consequences.

Authors:  Blythe D Shepard; Pamela L Tuma
Journal:  World J Gastroenterol       Date:  2009-03-14       Impact factor: 5.742

Review 6.  Metabolic reprogramming by class I and II histone deacetylases.

Authors:  Maria M Mihaylova; Reuben J Shaw
Journal:  Trends Endocrinol Metab       Date:  2012-10-09       Impact factor: 12.015

7.  Histone deacetylase inhibitors induce apoptosis in human eosinophils and neutrophils.

Authors:  Hannu Kankaanranta; Mirkka Janka-Junttila; Pinja Ilmarinen-Salo; Kazuhiro Ito; Ulla Jalonen; Misako Ito; Ian M Adcock; Eeva Moilanen; Xianzhi Zhang
Journal:  J Inflamm (Lond)       Date:  2010-02-04       Impact factor: 4.981

Review 8.  The tale of protein lysine acetylation in the cytoplasm.

Authors:  Karin Sadoul; Jin Wang; Boubou Diagouraga; Saadi Khochbin
Journal:  J Biomed Biotechnol       Date:  2010-11-28

Review 9.  A class of their own: exploring the nondeacetylase roles of class IIa HDACs in cardiovascular disease.

Authors:  Lillianne H Wright; Donald R Menick
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-05-20       Impact factor: 4.733

10.  Expression of histone deacetylase 8, a class I histone deacetylase, is restricted to cells showing smooth muscle differentiation in normal human tissues.

Authors:  David Waltregny; Laurence De Leval; Wendy Glénisson; Siv Ly Tran; Brian J North; Akeila Bellahcène; Ulrich Weidle; Eric Verdin; Vincent Castronovo
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.